Pharma news (page 3)

• 21 August 2018

  New Tablet Production Facility in Ingelheim for Global Drug Launches

  The new facility will develop and produce innovative tablet drugs for global markets, focusing on complex production technologies and maintaining the value chain in Germany.
• 

  11 April 2018

  Boehringer Ingelheim invests €65M in avian vaccines

  A new 5,700 sq m facility in Lyon will boost avian vaccine production, creating 42 jobs. The environmentally friendly site will triple inactivated vaccine capacity by 2020.
• 

  9 October 2017

  AkzoNobel Expands Pharma Salt Production in Denmark

  The Mariager site now produces 60% more pharmaceutical grade salt, meeting global demand for dialysis solutions, insulin, and baby food, driven by rising healthcare needs.
• 

  6 July 2017

  Fresenius Kabi Expands Portugal Plant

  Two new antibiotic production lines added, creating 80 jobs with a €17 million investment. The plant now spans 6,000 square meters and employs around 600 people.
• 

  17 June 2017

  DuPont Expands Axtra PHY Phytase Line in Europe

  New Axtra PHY products offer European animal producers faster nutrient uptake, lower feed costs, and reduced environmental impact, with optimized dosing for poultry and swine.
• 

  16 June 2017

  Takeda Completes New Manufacturing Facilities in Germany

  The new facility in Oranienburg, costing 100M euros, will start by end-2017, creating 180 jobs. It enhances production for global markets, supported by German and Brandenburg subsidies.

• 

  25 April 2017

  WACKER Enhances Ketene Production in Burghausen

  A new reactor for isopropenyl acetate boosts production capacity by 2,500 tons annually. WACKER also takes over sales of calcium acetylacetonate, enhancing supply chain integration and product quality.
• 

  7 March 2017

  Sederma Invests €10M in Facility Expansion

  The investment will boost innovation, production, and sustainability, enhancing product quality and reducing environmental impact. The focus remains on advanced, substantiated plant cell culture products.
• 

  5 December 2016

  Takeda to Invest €40M in New Dublin Facility

  The €40M investment will expand the Grange Castle site, creating 40 jobs and producing the oncology product NINLARO™. Supported by IDA Ireland, it highlights confidence in Ireland's pharma sector.
• 

  30 November 2016

  Takeda to Invest Over €100M in German Dengue Vaccine Plant

  The new plant in Singen will enhance dengue vaccine production, leveraging local expertise. Initial construction starts immediately, with production expected by 2019.
• 

  17 November 2016

  Bayer Begins Producing Pet Anti-Parasitic Drug in Spain

  The Langreo plant adds a fourth production line for imidacloprid, boosting output by six tonnes annually, alongside existing products like acetylsalicylic acid, butafosfan, and clotrimazole.
• 

  2 August 2016

  Jazz Pharmaceuticals Opens New Facility in Roscommon

  The new facility, supported by IDA Ireland, represents a €50 million investment and will employ up to 50 people. It has received FDA and Irish regulatory approval.
• 

  19 April 2016

  Sanofi Invests €300M in Belgium Site to Expand Monoclonal Antibodies Portfolio

  €300M investment will expand production capabilities, add new labs, and increase floor space by 8000 m². The site will support a pipeline of biologics, including monoclonal antibodies.
• 

  26 February 2016

  GSK Opens Two New Facilities After €12m Cork Investment

  The new Kilo Scale Facility and Technical Development Laboratory will enhance manufacturing of oncology medicines and improve existing products, reinforcing the Cork site's technical capabilities.
• 

  12 November 2015

  Sanofi Expands in Höchst

  Investing €200M, the company will build a fully automated cold warehouse and a multi-purpose building for medical tech, creating 500 jobs and expanding insulin production capabilities.
• 

  18 May 2015

  AstraZeneca to Invest $285M in New Biologics Facility in Sweden

  The new facility in Södertälje will focus on protein therapeutics, create 150-250 jobs, and support clinical trials and commercial production by 2019, enhancing the local life sciences sector.
• 

  20 May 2014

  Merck to Invest €50M in Bari Production Site

  The investment will expand production for rising biopharmaceutical demand, focusing on sterile filling and packaging. The Bari site benefits from skilled employees and good infrastructure.
• 

  14 March 2014

  Novo Nordisk Invests 550M DKK in New Purification Plant

  The new plant in Bagsværd will boost capacity for diabetes drug development, create 35 jobs, and be operational by late 2016. It features one purification line with potential for expansion.
• 

  10 February 2014

  Jazz Pharmaceuticals Begins Construction on New Facility in Ireland

  The new facility in Roscommon will cost $60-$68M, create 160 construction jobs, and 50 permanent jobs. Supported by IDA Ireland, it marks Jazz's first manufacturing site. Completion expected in 2016.
• 

  30 May 2013

  Myriant and ThyssenKrupp Uhde Scale Bio-Succinic Acid Production

  The alliance has successfully scaled bio-succinic acid production in Leuna, meeting commercial yield and quality targets, and securing process guarantees for future plants.
• 

  6 May 2013

  Novo Nordisk Invests DKK 380 Million in Kalundborg Plant

  The investment will create 50 jobs and convert existing facilities for semaglutide production, a new type 2 diabetes treatment. The plant will be operational by Q1 2014.
• 

  10 October 2012

  Novasep Invests €30M in New API Plant in France

  The new plant in Mourenx, France, will be operational in 18 months, featuring advanced chromatography and solvent recovery systems to meet rising demand for highly purified APIs.
• 

  22 March 2012

  GSK to Invest £500m in New UK Biopharmaceutical Facility

  The investment will create up to 1,000 jobs, boost the UK life-sciences sector, and enhance production at sites in Scotland. The new facility in Ulverston will focus on biopharmaceutical manufacturing.
• 

  9 May 2011

  DSM and Roquette to launch bio-based succinic acid plant in 2012

  The plant will produce 10 kilotons/year of bio-based succinic acid, offering a renewable alternative to fossil feedstocks. It will use a yeast-based fermentation process, improving eco-footprint and efficiency.
• 

  6 April 2011

  Opening of Cologne Technical Center for Bioprocess Learning

  The new center offers training on virus removal filters, membrane adsorbers, microfilters, and automated equipment, with support for process development and filtration optimization in four languages.
• 

  1 February 2011

  Sanofi Opens Cell Culture Plant in Höchst

  The new plant, costing EUR 30 million, will produce monoclonal antibodies for trials, doubling production capacity and enhancing the company's biopharmaceutical focus and market position.
• 

  29 March 2007

  GSK to Invest €250M in Irish Facility

  The investment will support production of lapatinib for advanced breast cancer treatment, creating up to 150 new jobs at the Currabinny site, established in 1975 and employing over 600 people.
• 

  27 August 2002

  Lipotec Invests €12M in New Gava Pharma Plant

  The new 16,000 sq ft plant near Barcelona will employ 80 people and triple production capacity in two years. Lipotec exports 80% of its raw materials for cosmetics, pharmaceuticals, and food industries.